FDA Declines to Approve of Epinephrine Alternative to EpiPen, Requests Further Study
The FDA's announcement requesting further study represents a step back in the process of 'neffy' becoming the first needle-free nasal spray epinephrine alternative.
Stay updated with breaking news from Published May. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA's announcement requesting further study represents a step back in the process of 'neffy' becoming the first needle-free nasal spray epinephrine alternative.
XACDURO is a new FDA-approved treatment used to fight against HABP/VABP infections caused by isolates of Acinetobacter baumannii-calcoaceticus complex, which can include those resistant to...
XACDURO is a new FDA-approved treatment used to fight against HABP/VABP infections caused by isolates of Acinetobacter baumannii-calcoaceticus complex, which can include those resistant to carbapenems (CRAB).In the U.S., it is estimated there are more than 40,000 cases of Acinetobacter each year and approximately 40...
As the weather cools and the days get shorter, curl up with one of these new books from Sun contributors. Below you’ll find descriptions from their publis...
Since 1980, The Link has been the most read newspaper on Concordia's campuses and the areas surrounding the university, reaching over 40,000 students and 5,000 members of the university faculty and staff weekly.